Literature DB >> 2553457

Uptake of transcobalamin II-bound cobalamin by HL-60 cells: effects of differentiation induction.

J Lindemans1, A C Kroes, J van Geel, J van Kapel, M Schoester, J Abels.   

Abstract

Binding and uptake of transcobalamin II-bound cobalamin by HL-60 promyelocytic leukemia cells proceed through receptor-mediated endocytosis. The affinity constant of the receptor for transcobalamin II-cobalamin was found to be 6.1 liter/nmol and the maximal rate of uptake 12 pmol/10(9) cells/h. This uptake is mediated by about 3000 receptor sites per cell. Evidence is presented that the receptor recirculates from the cell surface to the lysosomes and vice versa. Upon differentiation induction of the cells by either DMSO in granulocytic direction or by 1,25-dihydroxy-vitamin D3 in monocytic direction a rapid decline in cellular uptake and cell surface binding of the protein-bound vitamin ensues. In particular the internalization of the complex decreases faster than all other observed signs of the ongoing differentiation process, such as reduction in the OKT9-reactive transferrin receptor, increase in lineage-specific surface markers, and decrease in [3H]thymidine incorporation and actual cell proliferation. The transcobalamin II receptor on the cell surface appears to be a proliferation-associated membrane component in human leukemic cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2553457     DOI: 10.1016/0014-4827(89)90343-1

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  12 in total

1.  Immunohistochemical quantification of the vitamin B12 transport protein (TCII), cell surface receptor (TCII-R) and Ki-67 in human tumor xenografts.

Authors:  Annette M Sysel; Victor E Valli; Ray B Nagle; Joseph A Bauer
Journal:  Anticancer Res       Date:  2013-10       Impact factor: 2.480

2.  Down-regulation of transcobalamin receptor TCblR/CD320 by siRNA inhibits cobalamin uptake and proliferation of cells in culture.

Authors:  Shao-Chiang Lai; Yasumi Nakayama; Jeffrey M Sequeira; Edward V Quadros
Journal:  Exp Cell Res       Date:  2011-03-04       Impact factor: 3.905

3.  Characterization of the promoter region of TCblR/CD320 gene, the receptor for cellular uptake of transcobalamin-bound cobalamin.

Authors:  Wenxia Jiang; Jeffrey M Sequeira; Yasumi Nakayama; Shao-Chiang Lai; Edward V Quadros
Journal:  Gene       Date:  2010-07-11       Impact factor: 3.688

4.  Megalin-mediated endocytosis of transcobalamin-vitamin-B12 complexes suggests a role of the receptor in vitamin-B12 homeostasis.

Authors:  S K Moestrup; H Birn; P B Fischer; C M Petersen; P J Verroust; R B Sim; E I Christensen; E Nexø
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-06       Impact factor: 11.205

5.  Targeted delivery of saporin toxin by monoclonal antibody to the transcobalamin receptor, TCblR/CD320.

Authors:  Edward V Quadros; Yasumi Nakayama; Jeffrey M Sequeira
Journal:  Mol Cancer Ther       Date:  2010-09-21       Impact factor: 6.261

Review 6.  Advances in the understanding of cobalamin assimilation and metabolism.

Authors:  Edward V Quadros
Journal:  Br J Haematol       Date:  2009-10-12       Impact factor: 6.998

7.  Regulation of expression of transcobalamin II receptor in the rat.

Authors:  S Bose; S Seetharam; T G Hammond; B Seetharam
Journal:  Biochem J       Date:  1995-09-15       Impact factor: 3.857

8.  Plasma membrane delivery, endocytosis and turnover of transcobalamin receptor in polarized human intestinal epithelial cells.

Authors:  Santanu Bose; Seema Kalra; Raghunatha R Yammani; Rajiv Ahuja; Bellur Seetharam
Journal:  J Physiol       Date:  2007-03-08       Impact factor: 5.182

9.  Cobalamin related parameters and disease patterns in patients with increased serum cobalamin levels.

Authors:  Johan F B Arendt; Ebba Nexo
Journal:  PLoS One       Date:  2012-09-21       Impact factor: 3.240

10.  Immunohistochemical quantification of the cobalamin transport protein, cell surface receptor and Ki-67 in naturally occurring canine and feline malignant tumors and in adjacent normal tissues.

Authors:  Annette M Sysel; Victor E Valli; Joseph A Bauer
Journal:  Oncotarget       Date:  2015-02-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.